Keros Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Keros Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q3 2024.
  • Keros Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 39.3M shares, a 32.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 39.3M +9.58M +32.3% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 36.2M +6.51M +21.9% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 36.1M +6.52M +22.1% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 31.8M +4.3M +15.6% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 29.7M +3.6M +13.8% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 29.7M +5.23M +21.4% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 29.5M +5.55M +23.1% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 27.5M +3.57M +14.9% Dec 31, 2022 10-K 2024-02-28
Q3 2022 26.1M +2.68M +11.5% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 24.4M +1.1M +4.72% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 24M +732K +3.14% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 24M +782K +3.37% Dec 31, 2021 10-K 2023-03-03
Q3 2021 23.4M +3.21M +15.9% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 23.3M +3.17M +15.7% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 23.3M +20.8M +834% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 23.2M +20.8M +855% Dec 31, 2020 10-K 2022-03-09
Q3 2020 20.2M Sep 30, 2020 10-Q 2020-11-10
Q2 2020 20.2M Jun 30, 2020 10-Q 2020-08-13
Q1 2020 2.49M Mar 31, 2020 10-Q 2020-05-22
Q4 2019 2.43M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.